Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
HERC2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
OCA2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Oculocutaneous Albinism Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 28 | 22 |
|
Invitae Hypopigmentation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 83 | 46 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Invitae Broad Carrier Screen without X-linked Disorders Labcorp Genetics (formerly Invitae) LabCorp United States | 195 | 98 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Oculocutaneous Albinism Type 2 (OCAII) via the OCA2 Known Intragenic Gross Deletion PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 2 | 1 |
|
OCA2 Targeted Deletion Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
OCA2 Targeted Deletion Analysis Baylor Genetics United States | 2 | 1 |
|
OCA2 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
OCA2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 2 | 1 |
|
Baylor Genetics United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.